Settable bone void filler
The invention provides composite materials that form a biocompatible and bioresorbable settable ceramic-forming composition, and that possesses high strength when set and other desirable mechanical properties. The composite materials may include additive materials that provide beneficial advantages in the handling and physical properties of the material. When a hydrated precursor, the composite material is capable of being injected through cannulas for placement in treatment sites. The composite material provided desirable handling properties and sets in a clinically relevant time period.
1. A composite material comprising:
a. a reactive apatite forming composition comprising:
i. discrete particles consisting of tetracalcium phosphate,
ii. discrete particles consisting of hydroxyapatite,
iii. discrete particles consisting of monocalcium phosphate monohydrate,
iv. discrete particles consisting of alpha-tricalcium phosphate, and
v. discrete particles consisting of sodium phosphate dibasic dihydrate,
b. a water soluble polymer, and
c. a swelling additive as a particle, wherein said swelling additive comprises non-enzymatically processed, acid soluble collagen, and
wherein said composite material is in the form of a plurality of particles, and
wherein upon being contacted with a hydrating fluid, said reactive apatite forming composition forms a hydrated precursor within which the swelling additive is suspended as a particle, wherein the hydrated precursor forms an apatitic calcium phosphate via cementitious hardening of the hydrated precursor.
2. The composite material of claim 1 , wherein said composite material has a first volume at a first time of initial hydration, wherein the composite material has a second volume at a second, and later, time, that is greater than the first volume.
3. The composite material of claim 1 , wherein said water soluble polymer comprises at least one of polyalkylene oxide, polyvinylpyrrolidone, polyvinyl alcohol, hyaluronic acid, or combinations thereof.
4. The composite material of claim 1 , wherein said water soluble polymer comprises polyethylene glycol.
5. The composite material of claim 4 , wherein said polyethylene glycol has an average molecular weight of 1,000 to 20,000 Daltons.
6. The composite material of claim 1 , further comprising polymer microspheres.
7. The composite material of claim 1 , wherein said composite material has an average setting time of less than 10 minutes and is injectable with less than 22.5 poundfeet of force through an 8.5 gauge cannula.
8. The composite material of claim 1 , wherein said tetracalcium phosphate is present in an amount of from about 13 to about 23%, hydroxyapatite is present in an amount of from about 1.0 to about 2.2%, monocalcium phosphate monohydrate is present in an amount of from about 3.1 to about 4.35%, alpha-tricalcium phosphate is present in an amount of from about 49.4 to about 79.23%, and sodium phosphate dibasic dihydrate is present in an amount of from about 0.8 to about 1.15%, based on the total weight of the composite material.
9. The composite material according to claim 1 , wherein the composite material comprises particles comprising both the water soluble polymer and the non-enzymatically processed, acid soluble collagen together.
10. The composite material according to claim 9 , wherein the particles comprising both the water soluble polymer and the non-enzymatically processed, acid soluble collagen together are formed by dissolving the water soluble polymer in a slurry made from the non-enzymatically processed, acid soluble collagen, freeze drying the slurry, and then milling into particles.
11. The composite material according to claim 10 , wherein the water soluble polymer comprises polyethylene glycol.
12. The composite material according to claim 1 , wherein the non-enzymatically processed, acid soluble collagen and the water soluble polymer are present in a combined amount of from 3.5 to 10 wt %.
13. The composite material according to claim 1 , wherein the weight ratio of non-enzymatically processed, acid soluble collagen to water soluble polymer in the dry composite material is from 25:75 to 75:25.
14. The composite material according to claim 1 , wherein upon being hydrated the composite material is injectable with less than 22.5 poundfeet of force through an 8.5 gauge cannula.
15. A composite material in the form of a plurality of particles and comprising a reactive apatite forming composition, a first additive, and a second additive, said reactive apatite forming composition comprising discrete particles consisting of tetracalcium phosphate, discrete particles consisting of hydroxyapatite, discrete particles consisting of monocalcium phosphate monohydrate, discrete particles consisting of alpha-tricalcium phosphate, and discrete particles consisting of sodium phosphate dibasic dihydrate, said first additive comprising a swelling additive comprising collagen, wherein said collagen comprises non-enzymatically processed, acid soluble collagen, and said second additive comprising a water soluble polymer comprising polyethylene glycol, and wherein upon being contacted with a hydrating fluid, said reactive apatite forming composition forms a hydrated precursor within which the swelling additive is suspended as a particle, wherein the hydrated precursor forms an apatitic calcium phosphate via cementitious hardening of the hydrated precursor.
16. The composite material of claim 15 , wherein said composite material further comprises a third additive comprising poly(lactic-co-glycolic acid) co-polymer microspheres.
17. A kit comprising the composite material according to claim 15 and at least one of instructions for use, a mixing device, a delivery device, a hydrating fluid, a fluid processing unit, or a combination thereof.
18. A method of forming an apatitic composition, the method comprising the steps of: (a) providing a composite material in the form of a plurality of particles, the composite material comprising a reactive apatite forming composition, a first additive, and a second additive, said reactive apatite forming composition comprising discrete particles consisting of tetracalcium phosphate, discrete particles consisting of hydroxyapatite, discrete particles consisting of monocalcium phosphate monohydrate, discrete particles consisting of alpha-tricalcium phosphate, and discrete particles consisting of sodium phosphate dibasic dihydrate, said first additive comprising a swelling additive comprising collagen, wherein said collagen comprises non-enzymatically processed, acid soluble collagen, and said second additive comprising a water soluble polymer comprising polyethylene glycol; (b) adding an amount of hydrating fluid and mixing with said composite material to form a readily injectable hydrated precursor; wherein said first additive absorbs at least a portion of said hydrating fluid, and wherein the swelling additive is suspended within the hydrated precursor as a particle; (c) placing said composite material at a pre-determined site; and (d) allowing said composite material to harden to a solid.
19. The method of claim 18 , wherein the swelling additive retains a portion of hydrating fluid and does not release said portion of hydrating fluid upon exposure to compressive forces experienced during step c.